Josh Mandel-Brehm - Oct 15, 2024 Form 4 Insider Report for Camp4 Therapeutics Corp (CAMP)

Role
Chief Executive Officer, Director
Signature
By: /s/ Thomas Danielski, Attorney-in-Fact
Stock symbol
CAMP
Transactions as of
Oct 15, 2024
Transactions value $
$0
Form type
4
Date filed
10/15/2024, 05:45 PM
Previous filing
Oct 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CAMP Common Stock Conversion of derivative security +605 +0.22% 272K Oct 15, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CAMP Series B Preferred Stock Conversion of derivative security -6.79K -100% 0 Oct 15, 2024 Common Stock 605 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 15, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering.